Ian R. Kleckner on Relieving CIPN With Exercise

June 29, 2016
Ian R. Kleckner, PhD

Ian R. Kleckner, PhD, Research Assistant Professor at University of Rochester Medical Center, discusses the benefits of exercise for patients with chemotherapy-induced peripheral neuropathy (CIPN).

Ian R. Kleckner, PhD, Research Assistant Professor at University of Rochester Medical Center, discusses the benefits of exercise for patients with chemotherapy-induced peripheral neuropathy (CIPN).

In a study that compared patients on chemotherapy who were given an exercise regimen of walking and resistance training to a control group of patients who were on chemotherapy alone, patient-reported outcomes revealed that those who exercised had a significantly lower incidence of CIPN. Further, Klecker also found that exercise was particularly effective for older patients, in which the control group experienced a large increase of CIPN and the exercise arm had little, if any, increase.